Aktis Oncology, Inc. (AKTS)
17.37
+0.30
(+1.76%)
USD |
NASDAQ |
Apr 02, 16:00
17.34
-0.03
(-0.17%)
After-Hours: 20:00
Aktis Oncology EPS Diluted (Quarterly) : -0.2835 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Akari Therapeutics Plc | 0.00 |
| Alumis, Inc. | -0.8875 |
| Medline, Inc. | 0.2241 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.14M |
| Revenue (Quarterly) | 1.87M |
| Total Expenses (Quarterly) | 17.01M |
| Enterprise Value | 1.076B |
| Gross Profit Margin (Quarterly) | 62.83% |
| Profit Margin (Quarterly) | -809.5% |
| Earnings Yield | -2.95% |